Research
Metabolic adaptation
Intragastric balloons (IGBs) may improve steatosis and fibrosis in nonalcoholic fatty liver disease and improve quality of life and mental health in the short term.
Practitioners may consider IGBs as a short-term intervention for patients with nonalcoholic fatty liver disease.
StrongSupportsmedium confidence
In the short-term IGBs may improve steatosis and fibrosis in nonalcoholic fatty liver disease and improve quality of life and mental health.
Why this rating
The claim is supported by several studies confirming safety and efficacy.
Source
Endobariatrics: well past infancy and maturing rapidly
Shreesh Shrestha et al. · Current Opinion in Gastroenterology · 2022
reviewCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →